Cargando…
Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genes
BACKGROUND: Targeted therapies in oncology are promising but variants of uncertain significance (VUS) limit their use for clinical management and necessitate functional testing in vitro. Using BRCA1 and BRCA2 variants, which have consequences on PARP inhibitor sensitivity, and POLE variants, potenti...
Autores principales: | Billaud, Amandine, Chevalier, Louise-Marie, Augereau, Paule, Frenel, Jean-Sebastien, Passot, Christophe, Campone, Mario, Morel, Alain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576946/ https://www.ncbi.nlm.nih.gov/pubmed/34749799 http://dx.doi.org/10.1186/s13073-021-00976-x |
Ejemplares similares
-
Impact of HER2 Status on Pathological Response after Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer
por: Domergue, Camille, et al.
Publicado: (2022) -
Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing
por: Billaud, Amandine, et al.
Publicado: (2020) -
Hormonoresistance in advanced breast cancer: a new revolution in endocrine therapy
por: Augereau, Paule, et al.
Publicado: (2017) -
Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease
por: Fear, Vanessa S., et al.
Publicado: (2023) -
Targeting the PI3K/Akt/mTOR pathway in estrogen-receptor positive
HER2 negative advanced breast cancer
por: du Rusquec, Pauline, et al.
Publicado: (2020)